Research on the Diabetic Retinopathy Clinical Research Network (DRCRnet) has confirmed that anti-VEGF drugs are not only effective alternative for PRP in patients with PDR but also as the first-line treatment for DME (28). Here, VEGFA is linked to diabetic retinopathy.